Event Specialty: Bronchoscopy
Monday, October 8, 2018 at 5:15-5:30pm CHEST Conference, Room 216B San Antonio Convention Center
Auris Health, Inc., announced that Alexander C. Chen, MD, of the Washington University School of Medicine in St Louis, will present a study related to the Monarch Platform at the 2018 CHEST Annual Meeting taking place in San Antonio from October 6 to 10, 2018. Dr. Chen will be presenting "Robotic Assisted Bronchoscopic Biopsy of Peripheral Pulmonary Lesions in a Cadaveric Model with Simulated Tumor Targets" at the Late-Breaking Abstract session covering obstructive lung diseases on October 8, 2018. The presentation will discuss the use of the Monarch Platform in biopsying implanted simulated tumor targets in cadaveric human lungs. In particular, the robotic platform’s precision in performing peripheral lesion biopsy will be discussed. "Robotic-assisted bronchoscopy performed with the Monarch Platform has recently been described as a novel approach towards peripheral lesion biopsy, and preliminary studies have demonstrated improved peripheral reach in cadaveric human lungs compared with conventional thin bronchoscopes despite having similar sized outer diameters,” said Dr. Chen. “The Nodule Access study is the next logical step in evaluating potential benefits of the Monarch Platform. Findings are promising, and I look forward to evaluating this technology in the prospective multi-center clinical trial that will be initiated very soon.”CHEST 2018 Late Breaking Abstracts
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.